ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)
Japan flag Japan · Delayed Price · Currency is JPY
2,356.00
+49.00 (2.12%)
At close: Mar 5, 2026

TYO:4886 Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
66,90165,35062,86333,62035,67241,729
Market Cap Growth
25.13%3.96%86.98%-5.75%-14.52%34.20%
Enterprise Value
80,03962,60952,61428,08828,71947,720
Last Close Price
2356.002277.742141.351124.261177.741338.61
PE Ratio
13.6212.818.337.938.3215.38
PS Ratio
0.971.021.000.560.630.76
PB Ratio
0.900.941.010.620.730.94
P/TBV Ratio
1.121.121.070.670.841.28
P/FCF Ratio
--378.6911.6315.767.68
P/OCF Ratio
-26.3042.3010.0312.556.38
EV/Sales Ratio
1.170.980.840.470.510.87
EV/EBITDA Ratio
12.278.265.743.413.746.90
EV/EBIT Ratio
17.4411.748.095.505.9913.22
EV/FCF Ratio
--316.959.7212.698.78
Debt / Equity Ratio
0.180.160.150.230.290.37
Debt / EBITDA Ratio
-1.441.041.531.832.37
Debt / FCF Ratio
--57.144.376.213.02
Net Debt / Equity Ratio
0.100.00-0.12-0.10-0.060.13
Net Debt / EBITDA Ratio
1.07-0.03-0.85-0.64-0.400.85
Net Debt / FCF Ratio
-0.54-46.70-1.83-1.351.08
Asset Turnover
0.670.670.710.710.680.68
Inventory Turnover
1.371.401.691.952.062.10
Quick Ratio
1.061.151.371.881.971.41
Current Ratio
2.402.542.343.053.102.39
Return on Equity (ROE)
7.19%7.78%12.96%8.20%9.19%6.30%
Return on Assets (ROA)
2.91%3.48%4.57%3.75%3.61%2.77%
Return on Invested Capital (ROIC)
5.95%7.14%9.62%8.50%6.94%5.42%
Return on Capital Employed (ROCE)
5.40%6.90%9.70%7.40%7.10%5.50%
Earnings Yield
7.33%7.81%12.00%12.61%12.03%6.50%
FCF Yield
--0.73%0.26%8.60%6.34%13.03%
Dividend Yield
2.38%2.42%1.87%1.42%1.27%-
Payout Ratio
-25.00%10.50%10.66%9.28%17.84%
Buyback Yield / Dilution
-0.11%-0.12%-0.26%0.46%-0.06%-0.23%
Total Shareholder Return
2.22%2.30%1.61%1.88%1.21%-0.23%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.